Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
Saved in:
| Title: | Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. |
|---|---|
| Authors: | Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungenClinic Grosshansdorf, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de., Ciuleanu TE; Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania., Lee JS; Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Schenker M; Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania., Zurawski B; Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Mahave M; Department of Medical Oncology, Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile., Alexandru A; Department of Oncology, Institute of Oncology Bucuresti Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania., Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland., Pluzanski A; Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Caro RB; Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Sevilla, Seville, Spain., Linardou H; Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece., Burgers JA; Department of Thoracic Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Martinez-Marti A; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain., Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan., Axelrod R; Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania., Paz-Ares LG; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Borghaei H; Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania., O'Byrne KJ; Department of Medical Oncology, Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia., Li L; Global Biometric Sciences, Bristol Myers Squibb, Princeton, New Jersey., Bushong J; Oncology Clinical Development, Bristol Myers Squibb, Princeton, New Jersey., Gupta RG; Oncology Clinical Development, Bristol Myers Squibb, Princeton, New Jersey., Grootendorst DJ; Translational Sciences Oncology Imaging, Bristol Myers Squibb, Princeton, New Jersey., Eccles LJ; Global Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey., Brahmer JR; Department of Oncology, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland. |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Aug; Vol. 18 (8), pp. 1055-1069. Date of Electronic Publication: 2023 May 03. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37146754 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungenClinic Grosshansdorf, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de.<br /><searchLink fieldCode="AU" term="%22Ciuleanu+TE%22">Ciuleanu TE</searchLink>; Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Schenker+M%22">Schenker M</searchLink>; Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania.<br /><searchLink fieldCode="AU" term="%22Zurawski+B%22">Zurawski B</searchLink>; Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Mahave+M%22">Mahave M</searchLink>; Department of Medical Oncology, Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Alexandru+A%22">Alexandru A</searchLink>; Department of Oncology, Institute of Oncology Bucuresti Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Peters+S%22">Peters S</searchLink>; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pluzanski+A%22">Pluzanski A</searchLink>; Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Caro+RB%22">Caro RB</searchLink>; Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Sevilla, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Linardou+H%22">Linardou H</searchLink>; Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Burgers+JA%22">Burgers JA</searchLink>; Department of Thoracic Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nishio+M%22">Nishio M</searchLink>; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Martinez-Marti+A%22">Martinez-Marti A</searchLink>; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Azuma+K%22">Azuma K</searchLink>; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Axelrod+R%22">Axelrod R</searchLink>; Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Paz-Ares+LG%22">Paz-Ares LG</searchLink>; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramalingam+SS%22">Ramalingam SS</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22O'Byrne+KJ%22">O'Byrne KJ</searchLink>; Department of Medical Oncology, Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Global Biometric Sciences, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Bushong+J%22">Bushong J</searchLink>; Oncology Clinical Development, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Gupta+RG%22">Gupta RG</searchLink>; Oncology Clinical Development, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Grootendorst+DJ%22">Grootendorst DJ</searchLink>; Translational Sciences Oncology Imaging, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Eccles+LJ%22">Eccles LJ</searchLink>; Global Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Brahmer+JR%22">Brahmer JR</searchLink>; Department of Oncology, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101274235%22">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</searchLink> [J Thorac Oncol] 2023 Aug; Vol. 18 (8), pp. 1055-1069. <i>Date of Electronic Publication: </i>2023 May 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101274235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1556-1380 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215560864%22">15560864 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37146754 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtho.2023.04.021 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1055 Titles: – TitleFull: Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reck M – PersonEntity: Name: NameFull: Ciuleanu TE – PersonEntity: Name: NameFull: Lee JS – PersonEntity: Name: NameFull: Schenker M – PersonEntity: Name: NameFull: Zurawski B – PersonEntity: Name: NameFull: Kim SW – PersonEntity: Name: NameFull: Mahave M – PersonEntity: Name: NameFull: Alexandru A – PersonEntity: Name: NameFull: Peters S – PersonEntity: Name: NameFull: Pluzanski A – PersonEntity: Name: NameFull: Caro RB – PersonEntity: Name: NameFull: Linardou H – PersonEntity: Name: NameFull: Burgers JA – PersonEntity: Name: NameFull: Nishio M – PersonEntity: Name: NameFull: Martinez-Marti A – PersonEntity: Name: NameFull: Azuma K – PersonEntity: Name: NameFull: Axelrod R – PersonEntity: Name: NameFull: Paz-Ares LG – PersonEntity: Name: NameFull: Ramalingam SS – PersonEntity: Name: NameFull: Borghaei H – PersonEntity: Name: NameFull: O'Byrne KJ – PersonEntity: Name: NameFull: Li L – PersonEntity: Name: NameFull: Bushong J – PersonEntity: Name: NameFull: Gupta RG – PersonEntity: Name: NameFull: Grootendorst DJ – PersonEntity: Name: NameFull: Eccles LJ – PersonEntity: Name: NameFull: Brahmer JR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2023 Aug Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1556-1380 Numbering: – Type: volume Value: 18 – Type: issue Value: 8 Titles: – TitleFull: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Type: main |
| ResultId | 1 |
